Neuss, Germany

Stephan Prühs


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephan Prühs

Introduction

Stephan Prühs is a notable inventor based in Neuss, Germany. He has made significant contributions to the field of chemistry, particularly in the development of novel processes for synthesizing important compounds. His work is characterized by a focus on innovative methodologies that enhance efficiency and effectiveness in chemical production.

Latest Patents

One of Stephan Prühs' key patents is titled "Process for preparing epothilone derivatives by selective catalytic epoxidation." This invention describes a novel process for preparing an epothilone derivative using substituted pyridines and methyltrioxorhenium as a catalyst. This patent highlights his expertise in catalysis and organic synthesis, showcasing his ability to contribute to advancements in pharmaceutical chemistry. He holds 1 patent in this area.

Career Highlights

Stephan Prühs is associated with Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His role at Bayer has allowed him to work on cutting-edge research and development projects, contributing to the advancement of medical science. His innovative approach and dedication to his work have made him a valuable asset to the company.

Collaborations

Throughout his career, Stephan has collaborated with several talented individuals, including Johannes Platzek and Orlin Petrov. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field of chemistry.

Conclusion

Stephan Prühs exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of epothilone derivatives, demonstrate his commitment to advancing chemical processes. His work continues to impact the field positively, paving the way for future advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…